Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.79%237.31B | 4.98%944.96B | 6.76%239.2B | -1.40%900.15B | 2.39%222.42B | -5.25%227.53B | -4.17%226.14B | 2.05%224.06B | 16.95%912.9B | 5.23%217.22B |
| Cost of revenue | -0.22%192.98B | 3.84%763.67B | 4.35%193.41B | -2.91%735.43B | -0.61%179.19B | -8.01%184.94B | -5.37%185.95B | 3.17%185.36B | 18.16%757.49B | 5.41%180.28B |
| Gross profit | -3.18%44.33B | 10.06%181.29B | 18.29%45.79B | 5.99%164.72B | 17.04%43.23B | 8.96%42.6B | 1.80%40.19B | -3.00%38.71B | 11.41%155.41B | 4.37%36.93B |
| Operating expense | -2.77%34.08B | 6.05%142.21B | 10.40%35.05B | 9.88%134.1B | 14.93%35.62B | 7.96%34.06B | 7.24%32.66B | 9.36%31.75B | 17.08%122.03B | 9.63%31B |
| Staff costs | ---- | 0.15%50.77B | ---- | 12.41%50.7B | ---- | ---- | ---- | ---- | 13.89%45.1B | ---- |
| Selling and administrative expenses | ---- | 8.81%24.41B | ---- | -2.27%22.43B | ---- | ---- | ---- | ---- | 15.30%22.95B | ---- |
| -Selling and marketing expense | ---- | 8.81%24.41B | ---- | -2.27%22.43B | ---- | ---- | ---- | ---- | 15.30%22.95B | ---- |
| Depreciation and amortization | ---- | 12.72%13.37B | ---- | 17.42%11.86B | ---- | ---- | ---- | ---- | 9.84%10.1B | ---- |
| -Depreciation | ---- | 15.31%10.64B | ---- | 22.20%9.23B | ---- | ---- | ---- | ---- | 12.48%7.55B | ---- |
| -Amortization | ---- | 3.62%2.72B | ---- | 3.22%2.63B | ---- | ---- | ---- | ---- | 2.70%2.55B | ---- |
| Other operating expenses | ---- | 9.26%53.66B | ---- | 11.91%49.11B | ---- | ---- | ---- | ---- | 23.51%43.88B | ---- |
| Operating profit | -4.52%10.25B | 27.63%39.08B | 54.33%10.74B | -8.25%30.62B | 28.04%7.6B | 13.13%8.54B | -16.56%7.53B | -36.01%6.96B | -5.36%33.38B | -16.53%5.94B |
| Net non-operating interest income (expenses) | 21.86%-547M | 14.26%-2.69B | 23.25%-700M | -3.98%-3.13B | 31.67%-645M | 24.46%-695M | -30.09%-882M | -93.22%-912M | -195.49%-3.01B | -253.56%-944M |
| Non-operating interest income | -7.21%193M | 71.64%1.05B | 324.49%208M | 209.64%610M | 109.76%258M | 1,205.88%222M | 107.69%81M | 172.22%49M | 26.28%197M | 156.25%123M |
| Non-operating interest expense | -18.50%740M | -0.27%3.73B | -5.52%908M | 16.60%3.74B | -15.37%903M | -2.13%917M | 34.31%963M | 96.12%961M | 173.04%3.21B | 238.73%1.07B |
| Net investment income | 16.13%871M | -33.78%1.45B | -34.15%750M | 41.25%2.19B | 327.27%141M | 209.32%730M | -36.43%178M | 13.90%1.14B | -42.16%1.55B | -93.04%33M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -51M | -73.67%1.43B | 0 | 31.25%5.44B | -26.72%2.45B | 2,975.00%2.19B | 70.02%1.55B | -1,658.14%-756M | -29.21%4.14B | -10.05%3.35B |
| Income from associates and other participating interests | 19.34%216M | 72.36%979M | 129.11%181M | -25.95%568M | -53.97%168M | -22.78%183M | 68.29%138M | -4.82%79M | 174.39%767M | 131.77%365M |
| Special income (charges) | 42.86%-100M | 49.87%-1.69B | -3.55%-175M | 15.53%-3.36B | 17.94%-2.92B | 4.50%-276M | 110.14%7M | -186.44%-169M | -42.67%-3.98B | -53.47%-3.56B |
| Less:Other special charges | -42.86%100M | -52.81%512M | 3.55%175M | -4.91%1.09B | -10.64%647M | -4.50%276M | -110.14%-7M | 186.44%169M | 716.76%1.14B | 210.87%724M |
| Less:Write off | ---- | -48.46%1.17B | ---- | -19.80%2.28B | ---- | ---- | ---- | ---- | -4.57%2.84B | ---- |
| Other non-operating income (expenses) | -611.11%-128M | -225.79%-439M | -124.00%-18M | 15.95%349M | 4.17%150M | 195.08%180M | -243.59%-56M | 31.58%75M | -50.49%301M | -10.00%144M |
| Income before tax | -2.44%10.51B | 16.73%38.13B | 68.03%10.77B | -1.42%32.67B | 30.63%6.94B | 59.54%10.84B | -11.68%8.47B | -43.94%6.41B | -16.23%33.14B | -31.21%5.32B |
| Income tax | -11.78%2.8B | 20.86%11.86B | 69.73%3.17B | 9.91%9.81B | 40.14%2.43B | 42.54%3.13B | 32.12%2.39B | -41.45%1.87B | -29.62%8.93B | -58.12%1.73B |
| Net income | 1.45%7.71B | 14.95%26.27B | 67.36%7.6B | -5.61%22.85B | 26.02%4.51B | 67.62%7.71B | -21.82%6.08B | -44.92%4.54B | -9.91%24.21B | -0.11%3.58B |
| Net income continuous operations | 1.46%7.71B | 14.96%26.27B | 67.33%7.6B | -5.61%22.85B | 26.03%4.51B | 67.64%7.72B | -21.84%6.08B | -44.91%4.54B | -9.91%24.21B | -0.14%3.58B |
| Noncontrolling interests | 9.73%203M | 66.22%748M | 6.32%185M | -22.95%450M | 1,714.29%113M | -125.00%-40M | 30.13%203M | -36.73%174M | -37.34%584M | 94.35%-7M |
| Net income attributable to the company | 1.24%7.51B | 13.92%25.52B | 69.80%7.42B | -5.18%22.4B | 22.66%4.4B | 74.52%7.75B | -22.89%5.88B | -45.20%4.37B | -8.92%23.63B | -3.26%3.59B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.24%7.51B | 13.92%25.52B | 69.80%7.42B | -5.18%22.4B | 22.66%4.4B | 74.52%7.75B | -22.89%5.88B | -45.20%4.37B | -8.92%23.63B | -3.26%3.59B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 5.78%69.62 | 18.17%230.39 | 75.74%65.8164 | -2.30%194.96 | 26.04%38.77 | 78.98%67.71 | -20.59%51.03 | -43.84%37.45 | -6.52%199.54 | -0.97%30.76 |
| Diluted earnings per share | 5.78%69.62 | 18.17%230.39 | 75.74%65.8164 | -2.30%194.96 | 26.28%38.685 | 79.26%67.71 | -20.59%51.03 | -43.84%37.45 | -6.52%199.54 | -0.86%30.6348 |
| Dividend per share | 0 | 12.50%90 | 0 | 14.29%80 | 0.00%40 | 0 | 33.33%40 | 0 | 45.83%70 | 66.67%40 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |